Brusa, 37, of 64 Sampson St., South Grafton, charged with trafficking in marijuana, dismissed; possession of marijuana, found guilty, placed on probation for 2 years, fined $150, ordered to remain drug free and submit to random screening; drug violation near a school, dismissed; conspiracy to violate drug law, dismissed; possession of OxyContin, found guilty, placed on probation for 2 years concurrent with previous sentence; possession of Percocet, possession of Endocet, possession of Vicodin, possession of diazepam, possession of
Tolectin, possession of Lomotil, possession of marijuana with intent to distribute, continued without finding for 1 year with supervised probation, fined $50, ordered to remain drug free and submit to random screening.
Three other Mylan products have been approved for marketing since March: nortriptyline HC1, a generic version of Sandoz' antidepressant Pamelor; sulindac, a version of Merck & Co.'s anti-inflammatory Clinoril; and tolmetin sodium, a version of McNeil Pharmaceutical's anti-inflammatory
Tolectin.